Literature DB >> 14978633

Economic and personal impact of fecal and urinary incontinence.

Philip B Miner1.   

Abstract

Failure to control the elimination of urine or stool causes psychological stress, complicates medical illnesses and management, and has major economic consequences. Patients often describe the impact of both fecal and urinary incontinence in terms of shame and embarrassment and report that it causes them to isolate themselves from friends and family. Incontinence frequently results in an early decision to institutionalize elderly relatives because families have difficulty coping with incontinence at home. Not surprisingly, there is an increase in symptoms of depression and anxiety in patients with incontinence as well as degradation in quality of life that has been documented by standardized assessment instruments. The direct health care costs for urinary incontinence are estimated to be 16.3 billion dollars per year (1995 costs). Separate cost estimates for fecal incontinence are not available. There is an acute need for methodologically sound studies to document the economic and personal impact of incontinence to develop guidelines for the allocation of health care resources and research funding to this major public health problem. This need is especially great for fecal incontinence, for which there is much less health care economic data than for urinary incontinence.

Entities:  

Mesh:

Year:  2004        PMID: 14978633     DOI: 10.1053/j.gastro.2003.10.056

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  39 in total

1.  Filling in the gaps before clients fall through the cracks: physiotherapists have the skills to help clients preserve bone and prevent falls.

Authors:  Meena M Sran
Journal:  Physiother Can       Date:  2011-08-10       Impact factor: 1.037

2.  Changing trends of surgical approaches for uterine prolapse: an 11-year population-based nationwide descriptive study.

Authors:  Ming-Ping Wu; Cheng-Yu Long; Kuan-Hui Huang; Chin-Chen Chu; Ching-Chung Liang; Chao-Hsiun Tang
Journal:  Int Urogynecol J       Date:  2012-01-24       Impact factor: 2.894

3.  Reasons for non-disclosure of faecal incontinence: a comparison between two survey methods.

Authors:  L Bartlett; M Nowak; Y H Ho
Journal:  Tech Coloproctol       Date:  2007-08-03       Impact factor: 3.781

4.  New tined lead electrode in sacral neuromodulation: experience from a multicentre European study.

Authors:  Michele Spinelli; Ernest Weil; Edoardo Ostardo; Giulio Del Popolo; José L Ruiz-Cerdá; Gustav Kiss; John Heesakkers
Journal:  World J Urol       Date:  2005-06-30       Impact factor: 4.226

5.  Planned cesarean section versus planned vaginal delivery: comparison of lower urinary tract symptoms.

Authors:  Asa Ekström; Daniel Altman; Ingela Wiklund; Christina Larsson; Ellika Andolf
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-09-26

6.  Continence specialists use of quality of life information in routine practice: a national survey of practitioners.

Authors:  Kirstie L Haywood; Andrew M Garratt; Sandra Carrivick; Joanne Mangnall; Suzanne M Skevington
Journal:  Qual Life Res       Date:  2009-03-07       Impact factor: 4.147

Review 7.  Neuromodulation for fecal incontinence: an effective surgical intervention.

Authors:  Giuseppe Chiarioni; Olafur S Palsson; Corrado R Asteria; William E Whitehead
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

Review 8.  Impact of fecal incontinence and its treatment on quality of life in women.

Authors:  Isuzu Meyer; Holly E Richter
Journal:  Womens Health (Lond)       Date:  2015-03

9.  The anatomy of Trans-Obturator Posterior Anal Sling (TOPAS) and dynamics of potential mechanism of action.

Authors:  J Alshiek; P Rosenblatt; S A Shobeiri
Journal:  Tech Coloproctol       Date:  2019-08-03       Impact factor: 3.781

10.  Risk factors for fecal incontinence in older women.

Authors:  Mary K Townsend; Catherine A Matthews; William E Whitehead; Francine Grodstein
Journal:  Am J Gastroenterol       Date:  2012-10-23       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.